Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Earnings Calls In Brief

This article was originally published in The Gray Sheet

Executive Summary

J&J sees limited impact from financial crisis: Johnson & Johnson Chief Financial Officer Dominic Caruso says only "small pockets" of J&J's business were impacted by the global economic crisis in the third quarter. During the firm's Oct. 14 earnings call, Caruso cited certain products for elective procedures in sports medicine and women's health, in addition to some consumer health products. "They are still growing, but just subsiding a little bit in growth," he explained. J&J's Ethicon and Ethicon Endo-Surgery surgical business units reported revenue growth of 8.6% and 13%, respectively, over the prior-year period. The firm's DePuy orthopedics business reported 10% growth. The only declining device unit was Cordis, which dropped 6.6% due to struggling drug-eluting stent sales amidst increasing competition in the market. Overall, J&J's device business revenue grew 8.8% to $5.7 billion in the third quarter
Advertisement

Related Content

Baxter’s Relaunch Of Recalled Infusion Pump Will Add $75 Mil. In ’08 Sales
Baxter’s Relaunch Of Recalled Infusion Pump Will Add $75 Mil. In ’08 Sales
Stryker Spine Putty Approval “Significantly” Delayed, Firm Says
Advertisement
UsernamePublicRestriction

Register

MT026689

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel